Some studies confirmed that the interaction between MET and its ligand HGF plays an important role in GBM proliferation, invasion, survival, vascularization, treatment resistance, and recurrence (Hu H. et al., 2018; Cheng and Guo, 2019). This evidence concerns the gene MET and glioblastoma.